d ath roscl rose
play

dAthrosclrose Ziad Mallat, MD, PhD Department of Medicine, - PowerPoint PPT Presentation

Biologie de la Plaque dAthrosclrose Ziad Mallat, MD, PhD Department of Medicine, University of Cambridge, Cambridge, UK Inserm Atherosclerosis Kolodgie, et al. Heart 2004 Risk factors: ApoB/apoA1 ratio, diabetes, abdominal obesity,


  1. Biologie de la Plaque d’Athérosclérose Ziad Mallat, MD, PhD Department of Medicine, University of Cambridge, Cambridge, UK Inserm

  2. Atherosclerosis Kolodgie, et al. Heart 2004 Risk factors: ApoB/apoA1 ratio, diabetes, abdominal obesity, smoking, hypertension, psychosocial index, fruits/veg., exercise, alcohol

  3. Hanson GK. N Engl J Med 2005

  4. Effect of Subendothelial Retention of Atherogenic Lipoproteins on Atherosclerosis Wild type- control LDL Proteoglycan- binding-defective LDL Skalen et al. Nature, 2002;417:750-754.

  5. Cohen JC et al. Cell Metab 2014

  6. Composition of Atherogenic Sites in Fetal Aortas Percent of Atherogenic Sites Napoli et al. JCI, 1997, 100:2680-2690.

  7. Charo I, NEJM 2006

  8. Bornfeldt KE et al. Cell Metab 2011

  9. Bornfeldt KE et al. Cell Metab 2011

  10. Weber C et al. Nat Med 2011

  11. Debris of dead cells (thrombogenic) Mallat et al. 1999, 2000 Moore KJ & Tabas I. Cell 2011

  12. Bornfeldt KE et al. Cell Metab 2011

  13. Pro-atherogenic Th1 vs atheroprotective Tregs Mallat et al. 2003 Tr1 cells: IL-10 Clement et al., 2018 Ait-Oufella et al. 2006 nTreg and TGF- β Herbin et al. 2012 ApoB100-Tregs Mallat et al. 1999, 2001 Hanson GK. IL-10 and TGF- β N Engl J Med 2005

  14. Flego D et al.

  15. Klatzmann D & Abbas K, 2015

  16. Low-dose IL-2 to limit plaque inflammation Regulation of inflammation Maintenance of Protective Immunity tolerance Stable Apoptotic debris Clearance atherosclerotic Treg Lymph node plaque IL10 Treg Teff Restablishing Healthy Balance TGF b Treg IL10 TGF b Treg Low-dose IL2 IL10 TGF b Mac. Th2 IL4 Th1 Th2 IFN g IL12 Th1 TLRs, IL12/IL18… Treg IFN g Pathogenic immunity oxLDL, Teff Unstable HSP… atherosclerotic EC Thrombus plaque Pathogenic Immunity

  17. Ait-Oufella et al. 2010

  18. 2013 No CD20 CD20 mAb mAb Large infarction Small infarction Heart failure No heart failure Rituximab

  19. Low Wang CC et al. Circulation 2016

  20. CeMM, Medical University of Cambridge Inserm U970 British Heart Foundation Paris, France University Xuan LI Hafid AIT-OUFELLA of Vienna, Austria Andy SAGE JS SILVESTRE CJ. BINDER Marc CLEMENT Alain TEDGUI Duke University, USA Thomas F. TEDDER

  21. Gallego-Colon E et al. Atherosclerosis 2018

  22. Winkels H et al, Circ Res 2018

  23. Gallego-Colon E et al. Atherosclerosis 2018

  24. microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis, Volume: 37, Issue: 6, Pages: 1058-1067, DOI: (10.1161/ATVBAHA.116.308916)

  25. How Common Is Residual Cholesterol/Inflammatory Risk?

Recommend


More recommend